By Adria Calatayud

Novartis's off-patent medicines division Sandoz said Thursday that it plans to move to new headquarters next year, but remain based in Basel, Switzerland, following its planned separation from its current parent company.

Sandoz, which is due to be spun off from the Swiss pharmaceutical giant in the second half of 2023, said it expects to move from the Novartis campus to its new headquarters in mid-2024.

Write to Adria Calatayud at adria.calatayud@dowjones.com

(END) Dow Jones Newswires

June 01, 2023 02:00 ET (06:00 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Nov 2023 to Dec 2023 Click Here for more Novartis Charts.
Novartis (NYSE:NVS)
Historical Stock Chart
From Dec 2022 to Dec 2023 Click Here for more Novartis Charts.